- Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer
Hanqian Zeng et al, 2021, Aging CrossRef - CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang et al, 2022, Frontiers in Immunology CrossRef - Immune therapy: a new therapy for acute myeloid leukemia
Chen Tian et al, 2023, Blood Science CrossRef - Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
Mahmoud M. Morsy et al, 2024, Leukemia Research CrossRef - Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Yue Huang et al, 2022, ImmunoMedicine CrossRef - Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs)
Chiara Cassioli et al, 2022, International Journal of Molecular Sciences CrossRef - A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
Ying Chen et al, 2023, Frontiers in Pharmacology CrossRef - Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia
Xiangyu Wang et al, 2024, Annals of Hematology CrossRef - CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
Jolien Vanhooren et al, 2023, HemaSphere CrossRef - Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber et al, 2022, eBioMedicine CrossRef - Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations
Shyam A. Patel et al, 2023, Leukemia Research CrossRef - Chimeric antigen receptor T-cell therapy for T-ALL and AML
Wenwen Wei et al, 2022, Frontiers in Oncology CrossRef - Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
Maria Alvanou et al, 2023, Cancers CrossRef - The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
Yuan He et al, 2022, Cancers CrossRef - CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Jiawen Huang et al, 2022, Frontiers in Immunology CrossRef - Progress of research on PD-1/PD-L1 in leukemia
Huizhen Cao et al, 2023, Frontiers in Immunology CrossRef - Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis
Moazzam Shahzad et al, 2023, Frontiers in Immunology CrossRef - Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
Beatriz Guijarro-Albaladejo et al, 2024, Frontiers in Cell and Developmental Biology CrossRef - Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances
Martina Canichella et al, 2023, Cancers CrossRef - CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
Julia Zarychta et al, 2023, Cancers CrossRef